title: Portopulmonary hypertension in cirrhotic patients: Prevalence, clinical features and risk factors.
abstract: The incidence and clinical features of portopulmonary hypertension (POPH) have not been adequately described and it is currently unknown whether an association exists between the severity of POPH and liver function. Additionally, POPH risk factors are yet to be identified. The aim of this study was to determine the prevalence, describe the clinical features and investigate the potential risk factors of POPH. We conducted a study of 100 cirrhotic patients hospitalized between March 2011 and May 2012 at Tongji Hospital in Shanghai. The clinical characteristics of patients with and without POPH were analyzed. Clinical variables with a possible association with POPH were measured and pulmonary artery systolic pressure (PASP) was determined by cardiac Doppler echocardiography. Of the 100 patients enrolled in this study, 10 were diagnosed with POPH. Seven of the cases were mild, two were moderate and only one was severe; eight were attributed to viral infections. POPH was not detected in patients with schistosomal or alcoholic cirrhosis. Hemoglobin (Hb) levels were lower in patients with POPH compared to those without POPH (P<0.01) and the severity of POPH was not significantly correlated with Child-Pugh grade (R=-0.06, P=0.09). Hb levels, incidence of hepatitis C virus (HCV) infection and portal vein thrombosis differed between the two groups (P<0.05). Hb levels were identified as an independent risk factor associated with POPH and portal vein thrombosis may play an important role during the development of POPH. However, the severity of POPH was not associated with liver function.
authors: Division of Gastroenterology and Digestive Diseases Institute, Tongji Hospital of Tongji University School of Medicine, Shanghai 200065,  P.R. China.
authors: Hui-Song
authors: HS
authors: Chen
authors: Su-Rong
authors: SR
authors: Xing
authors: Wei-Guo
authors: WG
authors: Xu
authors: Fan
authors: F
authors: Yang
authors: Xiao-Long
authors: XL
authors: Qi
authors: LE-Min
authors: LM
authors: Wang
authors: Chang-Qing
authors: CQ
authors: Yang
keywords: hemoglobin; liver cirrhosis; portopulmonary hypertension; risk factors
references: Pulm Pharmacol Ther. 2007;20(2):135-40
references: 16753319
references: Hepatology. 1997 May;25(5):1282-4
references: 9141454
references: Liver Transpl. 2000 Jul;6(4):453-8
references: 10915168
references: J Am Coll Cardiol. 1991 Feb;17(2):492-8
references: 1991908
references: Lancet. 2004 May 1;363(9419):1461-8
references: 15121411
references: Hepatology. 1994 Nov;20(5):1359-63
references: 7927273
references: Br Med J. 1968 Jan 6;1(5583):22-4
references: 5636738
references: Gut. 2003 Sep;52(9):1355-62
references: 12912870
references: Am J Respir Crit Care Med. 2006 May 1;173(9):1023-30
references: 16456139
references: Semin Liver Dis. 2006 Aug;26(3):265-72
references: 16850376
references: J Am Coll Cardiol. 2003 Mar 19;41(6):1021-7
references: 12651052
references: Am J Cardiol. 2008 Jan 15;101(2):259-62
references: 18178418
references: Hepatology. 1997 May;25(5):1049-53
references: 9141416
references: Chest. 2004 Oct;126(4):1313-7
references: 15486398
references: Hepatol Int. 2012 Oct;6(4):783-9
references: 26201526
references: J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):5S-12S
references: 15194173
references: Liver Transpl. 2002 Nov;8(11):1051-4
references: 12424719
references: Mayo Clin Proc. 1996 Jun;71(6):543-51
references: 8642882
references: Clin Chest Med. 2007 Mar;28(1):203-18, ix
references: 17338936
references: Hepatology. 2008 Jul;48(1):196-203
references: 18537192
references: Gastroenterology. 1991 Feb;100(2):520-8
references: 1985048
references: J Am Coll Cardiol. 2001 Jun 1;37(7):1813-9
references: 11401116